PhaseBio Pharmaceuticals Inc
OTC:PHASQ
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
Price:
0.0001
USD
Market Closed
Market Cap:
$49.9
Cash Flow Statement
Cash Flow Statement
PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(39)
|
(99)
|
(131)
|
|
| Depreciation & Amortization |
0
|
1
|
2
|
|
| Stock-Based Compensation |
1
|
2
|
2
|
|
| Other Non-Cash Items |
2
|
42
|
52
|
|
| Cash Interest Paid |
1
|
1
|
1
|
|
| Change in Working Capital |
(2)
|
(4)
|
29
|
|
| Cash from Operating Activities |
(40)
N/A
|
(60)
-51%
|
(47)
+21%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(1)
|
(1)
|
(3)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-47%
|
(3)
-90%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
47
|
3
|
61
|
|
| Net Issuance of Debt |
7
|
(3)
|
(5)
|
|
| Other |
(0)
|
15
|
8
|
|
| Cash from Financing Activities |
54
N/A
|
15
-71%
|
64
+312%
|
|
| Change in Cash | ||||
| Net Change in Cash |
13
N/A
|
(46)
N/A
|
14
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(41)
N/A
|
(61)
-51%
|
(50)
+18%
|
|
Switch to:
Switch to:
See Also
Discover More
